EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/27/20
EDAP Announces Approval for Phase II Study Evaluating High Intensity Focused Ultrasound (HIFU) for Deep Invasive Endometriosis GlobeNewsWire • 08/25/20
EDAP TMS SA to Announce Second Quarter 2020 Financial Results on August 26, 2020GlobeNewsWire • 08/19/20
EDAP Announces Two Publications Highlighting Favorable HIFU Focal Therapy Outcomes in Journal of UrologyGlobeNewsWire • 08/18/20
EDAP Appoints Medical Technology Executive Marie Meynadier to its Board of DirectorsGlobeNewsWire • 06/30/20
EDAP Appoints Frank Van Hyfte as Vice President of Global Sales and MarketingGlobeNewsWire • 05/28/20
EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
EDAP ANNOUNCES EXCLUSIVE WORLDWIDE DISTRIBUTION RIGHTS TO EXACT IMAGING’S MICRO-ULTRASOUND TECHNOLOGIESGlobeNewsWire • 05/12/20
EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/31/20
EDAP Issues Letter to Shareholders Providing an Update on COVID-19 and the Potential Impact to OperationsGlobeNewsWire • 03/17/20
EDAP Showcases Focal One at the 12th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer GlobeNewsWire • 02/18/20
EDAP Announces Publication of Focal One® Endometriosis Study in the Journal Ultrasound in Obstetrics & GynecologyGlobeNewsWire • 12/19/19
EDAP Announces First Focal One® HIFU treatments at Farrer Park Hospital in SingaporeGlobeNewsWire • 11/26/19
EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/14/19